Gastric adenocarcinoma of fundic gland type (Chief Cell Predominant Type)

Proposal for a new entity of gastric adenocarcinoma

Hiroya Ueyama, Takashi Yao, Yutaka Nakashima, Katsuya Hirakawa, Yumi Oshiro, Minako Hirahashi, Akinori Iwashita, Sumio Watanabe

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Only a few cases of gastric adenocarcinoma of fundic gland type have been reported. Gastric adenocarcinoma with chief cell differentiation (GA-CCD) has been recently reported as a new variant of gastric adenocarcinoma. However, its clinicopathologic features are uncertain. To elucidate them, GACCDs exhibiting pepsinogen-I expression (10 lesions: Group A) and randomly selected gastric adenocarcinomas of differentiated type (111 lesions: Group B) were evaluated in this study. Cell differentiation by MUC2, MUC5AC, MUC6, CD10, pepsinogen-I, H+/K+-ATPase and chromogranin A, cell proliferation by Ki-67, and overexpression of p53 protein were evaluated immunohistochemically. In Group A, all GA-CCDs were located in the upper third of the stomach. Tumors were small, with the average maximum diameter ranging from 4 to 20 (average, 8.6) mm. Histologically, GA-CCDs were well-differentiated adenocarcinomas composed of pale gray-blue, basophilic columnar cells with mild nuclear atypia, resembling chief cells. Immunohistochemically, scattered positivity for H +/K+-ATPase was observed in addition to expression of pepsinogen-I and MUC6, indicating focal differentiation toward parietal cells. In Group B, pepsinogen-I was very focally expressed in 2 cases. As these 2 cases exhibited different clinicopathological and histologic features, they cannot be categorized as GA-CCD. Mild atypism, no lymphovascular invasion, low proliferative activity, no overexpression of p53, and no recurrence indicated less aggressiveness of GA-CCD. GA-CCD is rare, but it has distinct clinicopathological characteristics, especially in terms of tumor location, histologic features, phenotypic expression, and low-grade malignancy. We propose gastric adenocarcinoma of fundic gland type (chief cell predominant type) as a new entity of gastric adenocarcinoma.

Original languageEnglish
Pages (from-to)609-619
Number of pages11
JournalAmerican Journal of Surgical Pathology
Volume34
Issue number5
DOIs
Publication statusPublished - May 1 2010

Fingerprint

Stomach
Adenocarcinoma
Pepsinogen A
Cell Differentiation
Proton-Translocating ATPases
Chromogranin A
Neoplasms
Cell Proliferation
Recurrence

All Science Journal Classification (ASJC) codes

  • Anatomy
  • Surgery
  • Pathology and Forensic Medicine

Cite this

Gastric adenocarcinoma of fundic gland type (Chief Cell Predominant Type) : Proposal for a new entity of gastric adenocarcinoma. / Ueyama, Hiroya; Yao, Takashi; Nakashima, Yutaka; Hirakawa, Katsuya; Oshiro, Yumi; Hirahashi, Minako; Iwashita, Akinori; Watanabe, Sumio.

In: American Journal of Surgical Pathology, Vol. 34, No. 5, 01.05.2010, p. 609-619.

Research output: Contribution to journalArticle

Ueyama, Hiroya ; Yao, Takashi ; Nakashima, Yutaka ; Hirakawa, Katsuya ; Oshiro, Yumi ; Hirahashi, Minako ; Iwashita, Akinori ; Watanabe, Sumio. / Gastric adenocarcinoma of fundic gland type (Chief Cell Predominant Type) : Proposal for a new entity of gastric adenocarcinoma. In: American Journal of Surgical Pathology. 2010 ; Vol. 34, No. 5. pp. 609-619.
@article{f8b3bba0861c4055b702923fe942a025,
title = "Gastric adenocarcinoma of fundic gland type (Chief Cell Predominant Type): Proposal for a new entity of gastric adenocarcinoma",
abstract = "Only a few cases of gastric adenocarcinoma of fundic gland type have been reported. Gastric adenocarcinoma with chief cell differentiation (GA-CCD) has been recently reported as a new variant of gastric adenocarcinoma. However, its clinicopathologic features are uncertain. To elucidate them, GACCDs exhibiting pepsinogen-I expression (10 lesions: Group A) and randomly selected gastric adenocarcinomas of differentiated type (111 lesions: Group B) were evaluated in this study. Cell differentiation by MUC2, MUC5AC, MUC6, CD10, pepsinogen-I, H+/K+-ATPase and chromogranin A, cell proliferation by Ki-67, and overexpression of p53 protein were evaluated immunohistochemically. In Group A, all GA-CCDs were located in the upper third of the stomach. Tumors were small, with the average maximum diameter ranging from 4 to 20 (average, 8.6) mm. Histologically, GA-CCDs were well-differentiated adenocarcinomas composed of pale gray-blue, basophilic columnar cells with mild nuclear atypia, resembling chief cells. Immunohistochemically, scattered positivity for H +/K+-ATPase was observed in addition to expression of pepsinogen-I and MUC6, indicating focal differentiation toward parietal cells. In Group B, pepsinogen-I was very focally expressed in 2 cases. As these 2 cases exhibited different clinicopathological and histologic features, they cannot be categorized as GA-CCD. Mild atypism, no lymphovascular invasion, low proliferative activity, no overexpression of p53, and no recurrence indicated less aggressiveness of GA-CCD. GA-CCD is rare, but it has distinct clinicopathological characteristics, especially in terms of tumor location, histologic features, phenotypic expression, and low-grade malignancy. We propose gastric adenocarcinoma of fundic gland type (chief cell predominant type) as a new entity of gastric adenocarcinoma.",
author = "Hiroya Ueyama and Takashi Yao and Yutaka Nakashima and Katsuya Hirakawa and Yumi Oshiro and Minako Hirahashi and Akinori Iwashita and Sumio Watanabe",
year = "2010",
month = "5",
day = "1",
doi = "10.1097/PAS.0b013e3181d94d53",
language = "English",
volume = "34",
pages = "609--619",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Gastric adenocarcinoma of fundic gland type (Chief Cell Predominant Type)

T2 - Proposal for a new entity of gastric adenocarcinoma

AU - Ueyama, Hiroya

AU - Yao, Takashi

AU - Nakashima, Yutaka

AU - Hirakawa, Katsuya

AU - Oshiro, Yumi

AU - Hirahashi, Minako

AU - Iwashita, Akinori

AU - Watanabe, Sumio

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Only a few cases of gastric adenocarcinoma of fundic gland type have been reported. Gastric adenocarcinoma with chief cell differentiation (GA-CCD) has been recently reported as a new variant of gastric adenocarcinoma. However, its clinicopathologic features are uncertain. To elucidate them, GACCDs exhibiting pepsinogen-I expression (10 lesions: Group A) and randomly selected gastric adenocarcinomas of differentiated type (111 lesions: Group B) were evaluated in this study. Cell differentiation by MUC2, MUC5AC, MUC6, CD10, pepsinogen-I, H+/K+-ATPase and chromogranin A, cell proliferation by Ki-67, and overexpression of p53 protein were evaluated immunohistochemically. In Group A, all GA-CCDs were located in the upper third of the stomach. Tumors were small, with the average maximum diameter ranging from 4 to 20 (average, 8.6) mm. Histologically, GA-CCDs were well-differentiated adenocarcinomas composed of pale gray-blue, basophilic columnar cells with mild nuclear atypia, resembling chief cells. Immunohistochemically, scattered positivity for H +/K+-ATPase was observed in addition to expression of pepsinogen-I and MUC6, indicating focal differentiation toward parietal cells. In Group B, pepsinogen-I was very focally expressed in 2 cases. As these 2 cases exhibited different clinicopathological and histologic features, they cannot be categorized as GA-CCD. Mild atypism, no lymphovascular invasion, low proliferative activity, no overexpression of p53, and no recurrence indicated less aggressiveness of GA-CCD. GA-CCD is rare, but it has distinct clinicopathological characteristics, especially in terms of tumor location, histologic features, phenotypic expression, and low-grade malignancy. We propose gastric adenocarcinoma of fundic gland type (chief cell predominant type) as a new entity of gastric adenocarcinoma.

AB - Only a few cases of gastric adenocarcinoma of fundic gland type have been reported. Gastric adenocarcinoma with chief cell differentiation (GA-CCD) has been recently reported as a new variant of gastric adenocarcinoma. However, its clinicopathologic features are uncertain. To elucidate them, GACCDs exhibiting pepsinogen-I expression (10 lesions: Group A) and randomly selected gastric adenocarcinomas of differentiated type (111 lesions: Group B) were evaluated in this study. Cell differentiation by MUC2, MUC5AC, MUC6, CD10, pepsinogen-I, H+/K+-ATPase and chromogranin A, cell proliferation by Ki-67, and overexpression of p53 protein were evaluated immunohistochemically. In Group A, all GA-CCDs were located in the upper third of the stomach. Tumors were small, with the average maximum diameter ranging from 4 to 20 (average, 8.6) mm. Histologically, GA-CCDs were well-differentiated adenocarcinomas composed of pale gray-blue, basophilic columnar cells with mild nuclear atypia, resembling chief cells. Immunohistochemically, scattered positivity for H +/K+-ATPase was observed in addition to expression of pepsinogen-I and MUC6, indicating focal differentiation toward parietal cells. In Group B, pepsinogen-I was very focally expressed in 2 cases. As these 2 cases exhibited different clinicopathological and histologic features, they cannot be categorized as GA-CCD. Mild atypism, no lymphovascular invasion, low proliferative activity, no overexpression of p53, and no recurrence indicated less aggressiveness of GA-CCD. GA-CCD is rare, but it has distinct clinicopathological characteristics, especially in terms of tumor location, histologic features, phenotypic expression, and low-grade malignancy. We propose gastric adenocarcinoma of fundic gland type (chief cell predominant type) as a new entity of gastric adenocarcinoma.

UR - http://www.scopus.com/inward/record.url?scp=77951872265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951872265&partnerID=8YFLogxK

U2 - 10.1097/PAS.0b013e3181d94d53

DO - 10.1097/PAS.0b013e3181d94d53

M3 - Article

VL - 34

SP - 609

EP - 619

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 5

ER -